[{"Assets_0_Q1_USD":497873000.0,"CommonStockSharesOutstanding_0_Q1_shares":52635645.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-43737000.0,"NetIncomeLoss_1_Q1_USD":-48408000.0,"StockholdersEquity_0_Q1_USD":379810000.0,"Ticker":"CRSP","CIK":"1674416","name":"CRISPR THERAPEUTICS AG","OfficialName":"CRISPR Therapeutics AG Common Shares","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"4543904930.0","Country":"Switzerland","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190429"}]